BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 220 participants.
Also called NCT01603615
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 220 participants
- Sponsor
- Allergan
- Registry
-
NCT01603615 -
2012-000043-27
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, Hungary, Philippines, Poland, Russia, South Korea, Thailand, Türkiye
- Registry status
- Completed
Technical summary
Registry record NCT01603615. Allocation not applicable; no masking; primary purpose treatment. Start 2012-10-30 (actual); primary completion 2018-09-03 (actual). Results posted on 2019-08-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
- Condition
- Pediatrics
- Condition
- Muscle Spasticity
- Condition
- Cerebral Palsy
- Condition
- Stroke
- Intervention (Biological)
- Botulinum Toxin Type A
- Lead sponsor
- Allergan
Record details
- Record id
cardio:ct-nct01603615- Content hash
2b16722da0360171157e12098b9f1200e68f89b7338035d10425721a8bfc85b7